Bank Of America Corp Nurix Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 138,124 shares of NRIX stock, worth $2.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

138,124

Previous 221,327 37.59%

Holding current value

$2.76 Million

Previous $4.62 Million 32.89%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$18.93 - $25.69 $1.58 Million - $2.14 Million	-83,203 Reduced 37.59%	138,124 $3.1 Million
Q2 2024 Aug 14, 2024	BUY	$12.02 - $21.3 $1.49 Million - $2.64 Million	124,151 Added 127.76%	221,327 $4.62 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $15.66 $607,924 - $1.23 Million	78,240 Added 413.18%	97,176 $1.43 Million
Q4 2023 Feb 14, 2024	SELL	$4.25 - $10.71 $2.42 Million - $6.09 Million	-569,089 Reduced 96.78%	18,936 $195,000
Q2 2023 Aug 14, 2023	SELL	$8.7 - $13.28 $375,657 - $573,417	-43,179 Reduced 6.84%	588,025 $5.87 Million
Q1 2023 May 12, 2023	SELL	$8.56 - $13.26 $773,267 - $1.2 Million	-90,335 Reduced 12.52%	631,204 $5.61 Million
Q4 2022 Feb 10, 2023	BUY	$9.86 - $14.59 $5.83 Million - $8.63 Million	591,198 Added 453.58%	721,539 $7.92 Million
Q3 2022 Nov 14, 2022	BUY	$12.33 - $19.81 $524,357 - $842,459	42,527 Added 48.43%	130,341 $1.7 Million
Q2 2022 Aug 12, 2022	BUY	$7.88 - $14.82 $277,880 - $522,612	35,264 Added 67.11%	87,814 $1.11 Million
Q1 2022 May 16, 2022	SELL	$12.94 - $29.65 $465,387 - $1.07 Million	-35,965 Reduced 40.63%	52,550 $736,000
Q4 2021 Feb 08, 2022	BUY	$26.43 - $34.5 $355,298 - $463,783	13,443 Added 17.91%	88,515 $2.56 Million
Q3 2021 Nov 15, 2021	BUY	$22.71 - $36.69 $1.07 Million - $1.73 Million	47,163 Added 168.99%	75,072 $2.25 Million
Q2 2021 Sep 13, 2021	BUY	$24.21 - $35.89 $675,676 - $1 Million	27,909 New	27,909 $740,000

Others Institutions Holding NRIX

# of Institutions

181

Shares Held

68.1M

Call Options Held

78K

Put Options Held

53.8K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $942M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Nurix Therapeutics, Inc. Transaction History